What blood type and genetic predispositions are relevant for an 11-year-old patient of Indian origin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Work Relevant for an 11-Year-Old Patient of Indian Origin

For an 11-year-old child of Indian origin, the most critical blood tests include complete blood count with peripheral smear examination, hemoglobin electrophoresis to screen for β-thalassemia trait (carrier frequency 3.3% in India), and assessment for hemoglobin variants including HbD-Punjab and HbE, which are prevalent in the Indian subcontinent. 1, 2, 3

Essential Hematologic Screening

Thalassemia and Hemoglobinopathy Screening

  • β-thalassemia screening is paramount as India has a mean carrier frequency of 3.3%, with 7,500-12,000 children born annually with β-thalassemia major 1
  • Measure mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH), as carriers characteristically show low values with elevated hemoglobin A2 (>4%) 1
  • Hemoglobin electrophoresis should be performed to identify structural variants including HbD-Punjab (common in North-Western India but reported in South India), HbE, and HbS 2, 3
  • Screen for co-inheritance patterns such as HbSD-Punjab disease, which presents with severe clinical manifestations requiring management similar to sickle cell disease 3

Complete Blood Count with Differential

  • Obtain CBC to identify isolated thrombocytopenia versus pancytopenia, which helps differentiate primary from secondary causes 4
  • Peripheral blood smear examination by a qualified hematologist is mandatory to exclude pseudothrombocytopenia and identify morphologic abnormalities such as schistocytes, giant platelets, or leukocyte inclusion bodies 5, 4
  • Assess for microcytic hypochromic anemia patterns that may indicate iron deficiency (common in India due to nutritional factors) or thalassemia trait 2

Bleeding Disorder Assessment for Indian Population

Inherited Bleeding Disorders

  • Hemophilia A remains the most common inherited bleeding disorder in Indians (42.4%), closely followed by platelet function defects (39.4%), which differs from Western populations 6
  • Von Willebrand disease is relatively rare in the Indian population compared to industrialized countries 6
  • If bleeding history is present, measure prothrombin time (PT), activated partial thromboplastin time (aPTT), and consider specific factor levels (VIII, IX, XI) based on clinical suspicion 5
  • For patients of Ashkenazi Jewish ancestry (if applicable), factor XI deficiency screening may be reasonable given higher prevalence 5

Platelet Evaluation

  • Perform platelet count and assess for thrombocytopenia, which may indicate inherited conditions such as MYH9-related disease, Bernard-Soulier syndrome, or Wiskott-Aldrich syndrome 5, 4
  • Mild to moderate thrombocytopenia with increased platelet volume is common in certain genetic syndromes (e.g., 22q11.2 deletion syndrome) 5

Additional Relevant Testing Based on Clinical Context

Autoimmune and Metabolic Screening

  • Consider tissue transglutaminase antibodies with total serum IgA levels for celiac disease screening, particularly if growth failure, weight loss, or gastrointestinal symptoms are present 5
  • Measure antithyroid antibodies if clinical signs suggest thyroid dysfunction 5
  • Blood pressure measurement at each visit, with confirmation on three separate days if elevated (≥90th percentile for age, sex, height) 5

Ethnic-Specific Genetic Considerations

  • For moyamoya disease screening (if neurological symptoms present), Asian Americans have 4.6 times higher incidence than whites, with peak presentation in the first decade of life 5
  • HLA typing may be relevant if specific autoimmune conditions are suspected, as certain HLA haplotypes (HLA-B40 in children <10 years, HLA-B52 in those >10 years) are associated with moyamoya disease 5

Iron Status Assessment

  • Measure serum ferritin and transferrin saturation, as iron deficiency anemia is highly prevalent in India due to nutritional factors 2
  • Iron indices help differentiate iron deficiency from thalassemia trait, both of which cause microcytic anemia 1, 2

Critical Diagnostic Pitfalls to Avoid

  • Do not attribute all pallor to iron deficiency alone—always consider hemoglobinopathies in Indian children with microcytic anemia 2
  • Pseudothrombocytopenia due to EDTA-dependent platelet agglutination must be excluded before pursuing extensive thrombocytopenia workup 5
  • Co-inheritance of multiple hemoglobin variants (HbSD-Punjab, HbSE, HbD-Punjab E) can produce variable clinical presentations ranging from asymptomatic to severe, requiring careful interpretation of electrophoresis results 3
  • Reticulocyte count should be assessed if anemia is present to distinguish production defects from hemolytic processes 5

References

Research

Hemoglobinopathies in India--clinical and laboratory aspects.

Clinics in laboratory medicine, 2012

Research

Clinical and hematological presentation among Indian patients with common hemoglobin variants.

Clinica chimica acta; international journal of clinical chemistry, 2014

Guideline

Thrombocytopenia Causes and Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Spectrum of inherited bleeding disorders in Indians.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.